title: Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers.
abstract: OBJECTIVE
  The authors investigated the relationship between anxiety--a facet of the Revised NEO Personality Inventory dimension of neuroticism--and serotonin 5-HT(1A) receptor binding potential.
  
  
  METHODS
  Positron emission tomography with [(11)C]WAY-100635 was used to estimate regional 5-HT(1A) binding potential in 19 healthy volunteers who completed the Revised NEO Personality Inventory. Correlation coefficients were calculated to determine the degree of association between 5-HT(1A) binding potential and personality inventory measures.
  
  
  RESULTS
  There was a significant negative correlation between 5-HT(1A) binding potential and anxiety in four regions: the dorsolateral prefrontal cortex, anterior cingulate cortex, parietal cortex, and occipital cortex.
  
  
  CONCLUSIONS
  The inverse relationship between 5-HT(1A) receptor binding potential and anxiety is consistent with 1) animal models that have shown higher anxiety in mice lacking 5-HT(1A) receptors and 2) clinical trial data that have demonstrated antianxiety properties of partial 5-HT(1A) agonists.
authors.affiliation: Department of General Psychiatry, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. johannes.tauscher@akh-wien.ac.at
authors.forename: J
authors.initials: J
authors.lastname: Tauscher
authors.forename: R M
authors.initials: RM
authors.lastname: Bagby
authors.forename: M
authors.initials: M
authors.lastname: Javanmard
authors.forename: B K
authors.initials: BK
authors.lastname: Christensen
authors.forename: S
authors.initials: S
authors.lastname: Kasper
authors.forename: S
authors.initials: S
authors.lastname: Kapur
mesh_terms: D000328:Adult; D001007:Anxiety / Q000145:classification / Q000000981:diagnostic imaging / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002540:Cerebral Cortex / Q000000981:diagnostic imaging* / Q000378:metabolism*; D005260:Female; D006179:Gyrus Cinguli / Q000000981:diagnostic imaging / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009778:Occipital Lobe / Q000000981:diagnostic imaging / Q000378:metabolism; D010296:Parietal Lobe / Q000000981:diagnostic imaging / Q000378:metabolism; D010551:Personality / Q000145:classification; D010555:Personality Inventory / Q000706:statistics & numerical data*; D010879:Piperazines; D017397:Prefrontal Cortex / Q000000981:diagnostic imaging / Q000378:metabolism; D011725:Pyridines; D011985:Receptors, Serotonin / Q000378:metabolism*; D044263:Receptors, Serotonin, 5-HT1; D014055:Tomography, Emission-Computed / Q000706:statistics & numerical data*
chemical_list: D002250:Carbon Radioisotopes; D010879:Piperazines; D011725:Pyridines; D011985:Receptors, Serotonin; D044263:Receptors, Serotonin, 5-HT1; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide